Teleflex (TFX) Competitors $117.25 +1.05 (+0.90%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$117.22 -0.03 (-0.03%) As of 07/25/2025 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TFX vs. PODD, BAX, HOLX, MASI, GMED, ITGR, ATEC, ATRC, IART, and SRDXShould you be buying Teleflex stock or one of its competitors? The main competitors of Teleflex include Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Globus Medical (GMED), Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), and Surmodics (SRDX). These companies are all part of the "health care equipment" industry. Teleflex vs. Its Competitors Insulet Baxter International Hologic Masimo Globus Medical Integer Alphatec AtriCure Integra LifeSciences Surmodics Teleflex (NYSE:TFX) and Insulet (NASDAQ:PODD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends. Does the media favor TFX or PODD? In the previous week, Insulet had 6 more articles in the media than Teleflex. MarketBeat recorded 17 mentions for Insulet and 11 mentions for Teleflex. Insulet's average media sentiment score of 1.49 beat Teleflex's score of 1.00 indicating that Insulet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Insulet 14 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is TFX or PODD more profitable? Insulet has a net margin of 18.29% compared to Teleflex's net margin of 4.96%. Insulet's return on equity of 22.25% beat Teleflex's return on equity.Company Net Margins Return on Equity Return on Assets Teleflex4.96% 14.73% 8.79% Insulet 18.29%22.25%8.29% Which has more volatility and risk, TFX or PODD? Teleflex has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Insulet has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Do analysts recommend TFX or PODD? Teleflex currently has a consensus target price of $159.63, suggesting a potential upside of 36.14%. Insulet has a consensus target price of $321.00, suggesting a potential upside of 10.61%. Given Teleflex's higher possible upside, analysts clearly believe Teleflex is more favorable than Insulet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teleflex 1 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.09Insulet 0 Sell rating(s) 3 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.83 Do insiders and institutionals hold more shares of TFX or PODD? 95.6% of Teleflex shares are held by institutional investors. 1.4% of Teleflex shares are held by insiders. Comparatively, 0.4% of Insulet shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better earnings & valuation, TFX or PODD? Insulet has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeleflex$3.05B1.70$69.68M$3.1736.99Insulet$2.20B9.29$418.30M$5.5652.20 SummaryInsulet beats Teleflex on 11 of the 16 factors compared between the two stocks. Get Teleflex News Delivered to You Automatically Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TFX vs. The Competition Export to ExcelMetricTeleflexMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$5.13B$6.85B$5.69B$21.10BDividend Yield1.17%1.27%4.58%3.59%P/E Ratio36.9925.4528.1028.44Price / Sales1.7064.09432.4458.59Price / Cash4.5820.5536.2222.92Price / Book1.274.758.664.69Net Income$69.68M$176.14M$3.25B$995.51M7 Day Performance5.46%2.92%4.23%1.65%1 Month Performance-1.84%3.23%10.52%4.54%1 Year Performance-46.78%7.28%34.41%9.99% Teleflex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TFXTeleflex4.8673 of 5 stars$117.25+0.9%$159.63+36.1%-47.3%$5.13B$3.05B36.9914,100Positive NewsUpcoming EarningsPODDInsulet4.6055 of 5 stars$289.32-2.7%$321.00+10.9%+52.0%$20.36B$2.07B52.043,900Positive NewsBAXBaxter International4.2991 of 5 stars$28.71-3.3%$36.50+27.1%-16.7%$14.73B$10.64B-26.1038,000Upcoming EarningsHOLXHologic4.7289 of 5 stars$65.72-1.7%$78.75+19.8%-14.6%$14.65B$4.03B27.737,063Positive NewsUpcoming EarningsAnalyst RevisionMASIMasimo4.0208 of 5 stars$162.99-2.0%$191.60+17.6%+50.0%$8.84B$2.09B-17.775,600GMEDGlobus Medical4.9593 of 5 stars$57.09-1.2%$94.00+64.7%-24.1%$7.73B$2.52B42.605,300News CoverageAnalyst ForecastAnalyst RevisionITGRInteger3.3848 of 5 stars$119.73-1.7%$145.00+21.1%-6.5%$4.19B$1.72B56.7411,000Trending NewsEarnings ReportAnalyst ForecastATECAlphatec3.9384 of 5 stars$10.99-5.1%$17.89+62.8%-0.5%$1.61B$611.56M-9.56700News CoveragePositive NewsUpcoming EarningsATRCAtriCure3.4535 of 5 stars$30.72-4.2%$50.67+64.9%+33.9%$1.52B$465.31M-37.931,300News CoverageUpcoming EarningsIARTIntegra LifeSciences4.1375 of 5 stars$12.59-4.4%$18.63+47.9%-58.4%$978.39M$1.61B-33.134,396News CoverageUpcoming EarningsSRDXSurmodics3.9682 of 5 stars$30.87-0.5%$43.00+39.3%-13.4%$441.41M$126.08M-22.21450News CoverageUpcoming Earnings Related Companies and Tools Related Companies Insulet Alternatives Baxter International Alternatives Hologic Alternatives Masimo Alternatives Globus Medical Alternatives Integer Alternatives Alphatec Alternatives AtriCure Alternatives Integra LifeSciences Alternatives Surmodics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TFX) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teleflex Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Teleflex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.